CME Group (NASDAQ:CME) Issues Quarterly Earnings Results, Beats Estimates By $0.06 EPS

CME Group (NASDAQ:CME) issued its quarterly earnings results on Wednesday. The financial services provider reported $2.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.44 by $0.06, Briefing.com reports. CME Group had a return on equity of 12.45% and a net margin of 56.84%. The firm had revenue of $1.49 billion for the quarter, compared to analyst estimates of $1.48 billion. During the same period in the previous year, the company posted $2.42 earnings per share. The company’s quarterly revenue was up 3.2% compared to the same quarter last year.

CME Group Stock Down 0.0 %

Shares of CME opened at $212.54 on Friday. The company has a market capitalization of $76.51 billion, a P/E ratio of 24.18, a PEG ratio of 5.97 and a beta of 0.49. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02. CME Group has a one year low of $175.73 and a one year high of $223.80. The business’s 50 day simple moving average is $214.76 and its 200-day simple moving average is $211.93.

CME Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 26th. Stockholders of record on Friday, March 8th were issued a $1.15 dividend. This is an increase from CME Group’s previous quarterly dividend of $1.10. This represents a $4.60 annualized dividend and a dividend yield of 2.16%. The ex-dividend date of this dividend was Thursday, March 7th. CME Group’s payout ratio is presently 52.33%.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the company. Rosenblatt Securities reaffirmed a “sell” rating and set a $187.00 price objective (up from $185.00) on shares of CME Group in a report on Thursday. Barclays lifted their price objective on CME Group from $226.00 to $228.00 and gave the company an “equal weight” rating in a report on Thursday. JPMorgan Chase & Co. lifted their price objective on CME Group from $198.00 to $206.00 and gave the company a “neutral” rating in a report on Thursday. Argus lifted their price objective on CME Group from $225.00 to $245.00 and gave the company a “buy” rating in a report on Wednesday, March 6th. Finally, Bank of America lifted their price objective on CME Group from $209.00 to $216.00 and gave the company a “neutral” rating in a report on Thursday. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $217.80.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.